*Salmonella*, a prevalent foodborne pathogen that causes zoonoses worldwide, comprises 2 species, *Salmonella enterica* and *S*. *bongori*, and ≈2,600 serovars ([@R1]). In Taiwan, salmonellosis has been primarily caused by the *S. enterica* serovars Enteritidis, Typhimurium, Stanley, Newport, and Albany, which together caused 70% of salmonellosis infections during 2004--2012 ([@R2]). During this period, *Salmonella* Anatum was not prevalent, causing only 0.4% of the infections. However, since 2015, *Salmonella* Anatum infections have increased, and most isolates are multidrug resistant (MDR). We report the epidemiologic trend of *Salmonella* Anatum infection of humans, the clonal relationships among strains recovered during 2004--2017, and the resistance mechanism of the newly emerging MDR strains.

The Study
=========

To investigate the epidemiologic trend, we analyzed the data in the *Salmonella* fingerprint database constructed by the Taiwan Centers for Disease Control. The database comprises demographic and experimental data, including pulsed-field gel electrophoresis (PFGE) fingerprints obtained by using the PulseNet standardized PFGE protocol ([@R3]), serotypes obtained using PFGE pattern comparison and conventional methods ([@R4]), and antimicrobial drug susceptibility testing results for isolates collected from hospitals nationwide. We conducted whole-genome sequencing for 68 *Salmonella* Anatum isolates from humans and animals and 9 isolates from chicken carcasses and abbatoir environments by using the Illumina MiSeq platform (<https://www.illumina.com>) and identified resistance genes, incompatibility groups of plasmids, and sequence types by using the whole-genome sequencing data. To investigate clonal relationships and locations of resistance genes, we constructed a dendrogram for *Salmonella* Anatum strains with whole-genome single-nucleotide polymorphism profiles to assess genetic relatedness among strains and determined the complete genomic sequence of *Salmonella* Anatum strain R16.0676 with whole-genome sequencing data generated by using a MinION nanopore sequencer (<https://nanoporetech.com/products/minion>) and an Illumina MiSeq sequencer. To investigate mobility of resistance plasmids, we conducted conjugation experiments to transfer the resistance genes--carrying (R) plasmid from *Salmonella* Anatum strain R16.0676 into recipient *Escherichia coli* C600 and transferred an R plasmid from an *E. coli* transconjugant back to a rifampin-resistant mutant of *Salmonella* Anatum strain R13.0957 ([Appendix](#SD1){ref-type="local-data"}).

The *Salmonella* fingerprint database of the Taiwan Centers for Disease Control contained PFGE fingerprints for 34,160 *Salmonella* isolates recovered during 2004--2017, of which antimicrobial drug sensitivity test results were available for 23,018. *Salmonella* Anatum was not a prevalent serovar among those collected during 2004--2014 ([Figure 1](#F1){ref-type="fig"}). However, the number of *Salmonella* Anatum infections increased in 2015 and subsequently underwent another sharp increase in 2016 and 2017. In 2017, *Salmonella* Anatum accounted for 14.2% of *Salmonella* infections in Taiwan and ranked as the third most frequently identified serovar.

![Distribution of the 6 most frequently identified *Salmonella* *enterica* serovars in Taiwan, 2004--2017. Numbers indicate increasing frequency of *Salmonella* Anatum.](18-1103-F1){#F1}

Whole-genome single-nucleotide polymorphism analysis of *Salmonella* Anatum recovered from humans during 2004--2017 revealed 3 distinct lineages ([Figure 2](#F2){ref-type="fig"}). Strains of lineage (L) 1 were either pansusceptible or MDR; they mostly appeared during 2004--2009 ([Appendix](#SD1){ref-type="local-data"} Table 2). L2 comprised only 2 isolates, which emerged in 2005 and were pansusceptible. L3 comprised 2 sublineages; sublineage (SL) 3_1, first detected in 2011, was mostly pansusceptible, whereas SL3_2, which first emerged in 2013, was mostly MDR. The MDR strains of SL3_2 first appeared in 2015 and were resistant or of reduced susceptibility to 10 of the 14 antimicrobial drugs tested. SMX.642 was the predominant MDR strain, but the first 2 isolates recovered in 2013 were pansusceptible. Of the 9 isolates from chicken carcasses and abattoir environments, 5 belonged to SL3_1 and 4 to SL3_2. The new clone (L3) accounted for 91.9% of the total *Salmonella* Anatum infections during 2004--2017 and 99.6% in 2017. MDR strains accounted for 90.3% of the new clone recovered during 2011--2017 and 94.1% in 2017. All *Salmonella* Anatum isolates sequenced belonged to sequence type 64.

![Dendrogram of 36 representative *Salmonella enterica* serovar Anatum strains from Taiwan, 2004--2017, constructed with whole-genome SNP profiles with 883 SNPs. The complete genomic sequence of *Salmonella* Anatum strain GT-38 (GenBank accession no. CP013226) was used as the reference for SNP calling. Red, resistant; yellow, intermediate; green, susceptible. Lanes: 1, cefoxitin; 2, cefotaxime; 3, ceftazidime; 4, ertapenem; 5, nalidixic acid; 6, ciprofloxacin; 7, gentamicin; 8, ampicillin; 9, chloramphenicol; 10, streptomycin; 11, sulfamethoxazole; 12, tetracycline; 13, sulfamethoxazole/trimethoprim; 14, colistin. L, lineage; PFGE, pulsed-field gel electrophoresis; SNP, single-nucleotide polymorphism.](18-1103-F2){#F2}

The chromosomal sequence of strain R16.0676 was 4,674,190 bp (GenBank accession no. CP029800) and was not noted to carry any horizontally transferable resistance gene. R16.0676 harbored 2 plasmids, which were designated pR16.0676_90k (90,137 bp; IncC; accession no. CP029802) and pR16.0676_34k (34,063 bp; IncN3; accession no. CP029801). pR16.0676_90k harbored 11 resistance genes, *aadA2*, *bla*~DHA-1~, *dfrA23*, *floR*, *lnu(F)*, *qnrB4*, *strA*, *strB*, *sul1*, *sul2*, and *tet(A)*, which were distributed in 2 antimicrobial resistance islands, ARI1 and ARI2 ([Appendix](#SD1){ref-type="local-data"} Figure, panel A). ARI1 carried 5 resistance genes, *floR*, *strA*, *strB*, *sul2*, and *tet(A)*, and was found in many IncC plasmids in the National Center for Biotechnology Information database ([@R5]). ARI2 carried the other 6 resistance genes, *aadA2*, *bla*~DHA-1~, *dfrA23*, *lnu(F)*, *qnrB4*, and *sul1*. The resistance genes could confer resistance to cefoxitin, cefotaxime, ceftazidime, ampicillin, chloramphenicol, streptomycin, sulfonamide, tetracycline, and trimethoprim and reduced susceptibility to ciprofloxacin as shown by antimicrobial susceptibility testing ([Figure 2](#F2){ref-type="fig"}). pR16.0676_90k shared 79% sequence identity with a 272-kb plasmid, pECAZ155_KPC (GenBank accession no. CP019001.1), which harbored only the sequence of ARI1 but not ARI2. pR16.0676_34k did not carry any resistance gene ([Appendix](#SD1){ref-type="local-data"} Figure, panel B), but it shared 98% sequence identity with a 34.8-kb plasmid, pN-Cit (GenBank accession no. JQ996149.1). All MDR SL3_2 isolates, including the 4 isolates recovered from the abattoirs, harbored an IncC plasmid and the same 11 resistance genes identified in strain R16.0676. Strain R17.0132 acquired an additional *mcr-1* gene and was resistant to colistin ([Figure 2](#F2){ref-type="fig"}). We did not obtain any transconjugants with pR16.0676_90k, but we did obtain a transconjugant with a composite plasmid, which had the same sequences as pR16.0676_90k and pR16.0676_34k ([Appendix](#SD1){ref-type="local-data"} Figure, panel C). This 125-kb composite plasmid probably resulted from insertion of pR16.0676_90k into pR16.0676_34k through an insertion sequence 26--mediated transposition process. The resulting plasmid acquired an additional copy of insertion sequence 26 and an 8-bp tandem repeat in the insertion site. More than a dozen genes are typically required for conjugation ([@R6]). pR16.0676_90k harbored only 3 genes, and pR16.0676_34k contained at least 12 genes related to conjugation. Fusion of the 2 plasmids caused the composite plasmid to become self-transmissible. When the composite plasmid was transferred back into a rifampin-resistant mutant of *Salmonella* Anatum strain R13.0957, we obtained transconjugants harboring only a 58-kb or 83-kb R plasmid, which were derived from the 125-kb plasmid through deletions ([Appendix](#SD1){ref-type="local-data"} Figure, panel C). Accordingly, the composite plasmid was unstable in *Salmonella* Anatum.

Conclusions
===========

We identified a new *Salmonella* Anatum clone that emerged in Taiwan in 2011. During 2011--2014, strains of the new clone were not resistant and caused few infections. The dramatic increase in *Salmonella* Anatum infections that occurred during 2016--2017 was strongly associated with the emergence of MDR strains in 2015. The most crucial concern regarding emergence of the MDR *Salmonella* Anatum clone was that all MDR strains carry *bla*~DHA-1~, which encodes AmpC β-lactamase and confers resistance to β-lactam drugs, including third-generation cephalosporins. This resistance cannot be overcome by using β-lactam inhibitors. Because these MDR strains can cause numerous infections in humans and are prevalent in animals used for food, urgent control measures are needed.

###### Appendix

Additional methods and results from study of new multidrug-resistant *Salmonella enterica* serovar Anatum clone, Taiwan, 2017--2017.
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